UB Paderborn / Katalog / Suche / in CDI

Generation and Characterization of ALX-0171, a Potent Novel Therapeutic Nanobody for the Treatment of Respiratory Syncytial Virus Infection

Antimicrobial agents and chemotherapy, 2016-01, Vol.60 (1), p.6-13

2016

Volltextzugriff (PDF)

The viral protein corona directs viral pathogenesis and amyloid aggregation

Nature communications, 2019-05, Vol.10 (1), p.2331-16, Article 2331

2019

Volltextzugriff (PDF)

Respiratory Syncytial Virus: Targeting the G Protein Provides a New Approach for an Old Problem

Journal of virology, 2018-02, Vol.92 (3)

2018

Volltextzugriff (PDF)

EGFR Interacts with the Fusion Protein of Respiratory Syncytial Virus Strain 2-20 and Mediates Infection and Mucin Expression

PLoS pathogens, 2016-05, Vol.12 (5), p.e1005622-e1005622

2016

Volltextzugriff (PDF)

Comparison of SARS-CoV-2 Evolution in Paediatric Primary Airway Epithelial Cell Cultures Compared with Vero-Derived Cell Lines

Viruses, 2022-02, Vol.14 (2), p.325

2022

Volltextzugriff (PDF)

The respiratory syncytial virus G protein conserved domain induces a persistent and protective antibody response in rodents

PloS one, 2012-03, Vol.7 (3), p.e34331-e34331

2012

Volltextzugriff (PDF)

Single-Stranded Oligonucleotide-Mediated Inhibition of Respiratory Syncytial Virus Infection

Frontiers in immunology, 2020, Vol.11, p.580547-580547

2020

Volltextzugriff (PDF)

Skin Dendritic Cell Targeting via Microneedle Arrays Laden with Antigen-Encapsulated Poly‑d,l‑lactide-co-Glycolide Nanoparticles Induces Efficient Antitumor and Antiviral Immune Responses

ACS nano, 2013-03, Vol.7 (3), p.2042-2055

2013

Volltextzugriff (PDF)

Respiratory syncytial virus interaction with human airway epithelium

Trends in microbiology (Regular ed.), 2013-05, Vol.21 (5), p.238-244

2013

Volltextzugriff (PDF)

Airway Surface Liquid Has Innate Antiviral Activity That Is Reduced in Cystic Fibrosis

American journal of respiratory cell and molecular biology, 2020-01, Vol.62 (1), p.104-111

2020

Volltextzugriff (PDF)

Dissolving Microneedle Delivery of Nanoparticle-Encapsulated Antigen Elicits Efficient Cross-Priming and Th1 Immune Responses by Murine Langerhans Cells

Journal of investigative dermatology, 2015-02, Vol.135 (2), p.425-434

2015

Volltextzugriff (PDF)

Respiratory syncytial virus, an ongoing medical dilemma: an expert commentary on respiratory syncytial virus prophylactic and therapeutic pharmaceuticals currently in clinical trials

Influenza and other respiratory viruses, 2015-07, Vol.9 (4), p.169-178

2015

Volltextzugriff (PDF)

Induction and Antagonism of Antiviral Responses in Respiratory Syncytial Virus-Infected Pediatric Airway Epithelium

Journal of virology, 2015-12, Vol.89 (24), p.12309-12318

2015

Volltextzugriff (PDF)

Pro‐inflammatory mediator responses from neonatal airway epithelial cells and early childhood wheeze

Pediatric pulmonology, 2018-01, Vol.53 (1), p.10-16

2018

Volltextzugriff (PDF)

Protective Levels of Polysaccharide-Specific Maternal Antibodies May Enhance the Immune Response Elicited by Pneumococcal Conjugates in Neonatal and Infant Mice

Infection and Immunity, 2005-02, Vol.73 (2), p.956-964

2005

Volltextzugriff (PDF)

Immunization of Female Mice with Glycoconjugates Protects Their Offspring against Encapsulated Bacteria

Infection and Immunity, 2004-01, Vol.72 (1), p.187-195

2004

Volltextzugriff (PDF)

De novo generation of a non-segmented negative strand RNA virus with a bicistronic gene

Virus research, 2009-03, Vol.140 (1), p.40-48

2009

Volltextzugriff (PDF)

The immunogenicity, protective efficacy and safety of BBG2Na, a subunit respiratory syncytial virus (RSV) vaccine candidate, against RSV-B

Vaccine, 2003-12, Vol.22 (2), p.168-176

2003

Volltextzugriff (PDF)

Evaluation of BBG2Na in infant macaques: specific immune responses after vaccination and RSV challenge

Vaccine, 2004-02, Vol.22 (8), p.915-922

2004

Volltextzugriff (PDF)

Differential Histopathology and Chemokine Gene Expression in Lung Tissues following Respiratory Syncytial Virus (RSV) Challenge of Formalin-Inactivated RSV- or BBG2Na-Immunized Mice

Journal of Virology, 2001-12, Vol.75 (24), p.12421-12430

2001

Volltextzugriff (PDF)

Protective Efficacy against Respiratory Syncytial Virus following Murine Neonatal Immunization with BBG2Na Vaccine: Influence of Adjuvants and Maternal Antibodies

The Journal of infectious diseases, 1999-06, Vol.179 (6), p.1326-1333

1999

Volltextzugriff (PDF)

Enhanced pulmonary immunopathology following neonatal priming with formalin-inactivated respiratory syncytial virus but not with the BBG2NA vaccine candidate

Vaccine, 2003-06, Vol.21 (19), p.2651-2660

2003

Volltextzugriff (PDF)

Identification of Multiple Protective Epitopes (Protectopes) in the Central Conserved Domain of a Prototype Human Respiratory Syncytial Virus G Protein

Journal of Virology, 1999-07, Vol.73 (7), p.5637-5645

1999

Volltextzugriff (PDF)

Challenge of BALB/c Mice with Respiratory Syncytial Virus Does Not Enhance the Th2 Pathway Induced after Immunization with a Recombinant G Fusion Protein, BBG2NA, in Aluminum Hydroxide

The Journal of infectious diseases, 1997-09, Vol.176 (3), p.560-569

1997

Volltextzugriff (PDF)

CD4+ T-Cell-Mediated Antiviral Protection of the Upper Respiratory Tract in BALB/c Mice following Parenteral Immunization with a Recombinant Respiratory Syncytial Virus G Protein Fragment

Journal of Virology, 2000-04, Vol.74 (8), p.3455-3463

2000

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Generation and Characterization of ALX-0171, a Potent Novel Therapeutic Nanobody for the Treatment of Respiratory Syncytial Virus Infection

The viral protein corona directs viral pathogenesis and amyloid aggregation

Respiratory Syncytial Virus: Targeting the G Protein Provides a New Approach for an Old Problem

EGFR Interacts with the Fusion Protein of Respiratory Syncytial Virus Strain 2-20 and Mediates Infection and Mucin Expression

Comparison of SARS-CoV-2 Evolution in Paediatric Primary Airway Epithelial Cell Cultures Compared with Vero-Derived Cell Lines

The respiratory syncytial virus G protein conserved domain induces a persistent and protective antibody response in rodents

Single-Stranded Oligonucleotide-Mediated Inhibition of Respiratory Syncytial Virus Infection

Skin Dendritic Cell Targeting via Microneedle Arrays Laden with Antigen-Encapsulated Poly‑d,l‑lactide-co-Glycolide Nanoparticles Induces Efficient Antitumor and Antiviral Immune Responses

Respiratory syncytial virus interaction with human airway epithelium

Airway Surface Liquid Has Innate Antiviral Activity That Is Reduced in Cystic Fibrosis

Dissolving Microneedle Delivery of Nanoparticle-Encapsulated Antigen Elicits Efficient Cross-Priming and Th1 Immune Responses by Murine Langerhans Cells

Respiratory syncytial virus, an ongoing medical dilemma: an expert commentary on respiratory syncytial virus prophylactic and therapeutic pharmaceuticals currently in clinical trials

Induction and Antagonism of Antiviral Responses in Respiratory Syncytial Virus-Infected Pediatric Airway Epithelium

Pro‐inflammatory mediator responses from neonatal airway epithelial cells and early childhood wheeze

Protective Levels of Polysaccharide-Specific Maternal Antibodies May Enhance the Immune Response Elicited by Pneumococcal Conjugates in Neonatal and Infant Mice

Immunization of Female Mice with Glycoconjugates Protects Their Offspring against Encapsulated Bacteria

De novo generation of a non-segmented negative strand RNA virus with a bicistronic gene

The immunogenicity, protective efficacy and safety of BBG2Na, a subunit respiratory syncytial virus (RSV) vaccine candidate, against RSV-B

Evaluation of BBG2Na in infant macaques: specific immune responses after vaccination and RSV challenge

Differential Histopathology and Chemokine Gene Expression in Lung Tissues following Respiratory Syncytial Virus (RSV) Challenge of Formalin-Inactivated RSV- or BBG2Na-Immunized Mice

Protective Efficacy against Respiratory Syncytial Virus following Murine Neonatal Immunization with BBG2Na Vaccine: Influence of Adjuvants and Maternal Antibodies

Enhanced pulmonary immunopathology following neonatal priming with formalin-inactivated respiratory syncytial virus but not with the BBG2NA vaccine candidate

Identification of Multiple Protective Epitopes (Protectopes) in the Central Conserved Domain of a Prototype Human Respiratory Syncytial Virus G Protein

Challenge of BALB/c Mice with Respiratory Syncytial Virus Does Not Enhance the Th2 Pathway Induced after Immunization with a Recombinant G Fusion Protein, BBG2NA, in Aluminum Hydroxide

CD4+ T-Cell-Mediated Antiviral Protection of the Upper Respiratory Tract in BALB/c Mice following Parenteral Immunization with a Recombinant Respiratory Syncytial Virus G Protein Fragment

Aktive Filter

Suchergebnisse filtern